Aligos Therapeutics Inc (ALGS) Annual Balance Sheets

Annual · GAAP · USD millions
Access ALGS quarterly Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Aligos Therapeutics Inc's financial structure and capital allocation.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent18.30
Short-term Investments, Total59.54
Cash & Short-term Investments77.00
Other Current Assets5.02
Total Current Assets82.86
Equipment/Property/Plant Net1.87
Long-term investments0.00
Other Assets, Noncurrent3.80
Restricted Cash Current0.11
Operating Lease Right Of Use Asset3.09
Total Assets88.53
Liabilities
Accounts Payable, Current AC3.98
Accrued Liabilities, Current AC13.53
Other Liabilities, Current0.00
Deferred Revenue, Current DE0.00
Total Current Liabilities21.23
Total Long-term Debt0.00
Other liabilities, Noncurrent13.76
Operating Lease Liability Current3.58
Finance Lease Liability Current0.15
Total Liabilities34.99
Stockholders' Equity
Operating Lease Liability Noncurrent1.53
Finance Lease Liability Noncurrent-
Common Stock Value0.01
Additional Paid In Capital Common Stock695.27
Retained Earnings / Accumulated Deficit-642.20
Other Equity-1.06
Common Stockholder's Equity53.55
Total Stockholder's Equity53.55
Liabilities & Stockholder's Equity88.53
4 historic quarters locked

Sign in to unlock the full Aligos Therapeutics Inc balance sheet history.

About Aligos Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-092614

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.